
Work Here?
Medeloop is an AI-driven platform that speeds up clinical and public health research. It serves researchers, pharmaceutical companies, and healthcare providers by covering the full research lifecycle—from generating hypotheses and helping with funding to managing studies and analyzing data. The platform is accessed through subscriptions and includes tools like two-way messaging for patient-care team communication, advanced analytics to identify biomarkers and drug targets, and features for grant writing and scientific publication. Medeloop integrates and harmonizes large health data sources to streamline research workflows. This helps shorten discovery timelines and aim for better patient outcomes. The company operates in health-tech with a focus on early-stage clinical research and trials, positioning itself as a comprehensive, data-driven research platform rather than a collection of isolated tools.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$23.5M
Headquarters
Palo Alto, California
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$23.5M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Flexible Work Hours
Professional Development Budget
This powerful collaboration unites HealthVerity's extensive, privacy-compliant data ecosystem with Medeloop's cutting-edge AI Agent Analytics technology, enabling customers to uncover insights with unprecedented speed and transform vast, complex datasets into clear, actionable intelligence.
Medeloop, a medical research platform, has raised $15.5 million in Series A funding led by Inovia Capital, with support from Icon Ventures, General Catalyst, Maven Ventures, and new investors like Healthier Capital, Up2 Opportunity Fund, and CFO Advisors.
Medeloop has raised $15.5M in Series A funding, led by Inovia Capital with participation from Icon Ventures, General Catalyst, and Maven Ventures. The funds will enhance Medeloop's AI-driven medical research platform, which accelerates research by using autonomous AI agents and a graph database for faster data analysis. The platform includes tools for grant applications, clinical study management, data analysis, and manuscript publication.
MENLO PARK, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) - Medeloop, the pioneering medical research platform announces the close of its $15.5 million Series A funding round.
MENLO PARK, Calif., May 06, 2024 (GLOBE NEWSWIRE) - Medeloop, a trailblazer AI platform for clinical research is proud to announce the addition of Amir Dan Rubin to its board of directors.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$23.5M
Headquarters
Palo Alto, California
Founded
2021
Find jobs on Simplify and start your career today